Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Liver Diseases

Treatments: Drug: Azathioprine

Study type: Observational

Funder types: Industry

Identifiers

NCT01390766

112305

Details and patient eligibility

About

This post-marketing surveillance (PMS) study is designed to investigate the efficacy and safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.

Enrollment: 41 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who undergo liver transplantation and azathioprine tablet was administered

Exclusion criteria

As this is PMS study, there are no exclusion criteria but contraindications are as follows.

• Subjects with hypersensitivity to the ingredients of azathioprine tablet
• Subjects who is pregnant or might be pregnant
• Subjects whose white count is lower than 3000/cubic millimeter

Trial design

41 participants in 1 patient group

Subjects prescribed azathioprine tablet

Description:

Subjects prescribed azathioprine tablet during study period after the liver transplantation

Treatment:

Drug: Azathioprine